期刊
ANNALS OF NEUROLOGY
卷 70, 期 5, 页码 857-861出版社
WILEY
DOI: 10.1002/ana.22608
关键词
-
资金
- National Institute on Aging [P50 A605681, P01 A6026276, P01 A603991]
- National Insitiute of Neurological Disorders and stroke [P30 NS048056]
- Dana Foundation
- Charles F. and Joanne Knight Alzheimer's Disease Initiative
- Barnes Jewish Hospital Foundation
- AstraZeneca
- Genentech
- Pfizer
- AVID Radiopharmaceuticals
- NIA
Amyloid-beta (A beta) accumulation was evaluated with 2 [11C]Pittsburgh compound B (PiB) positron emission tomography scans about 2.5 years apart in 146 cognitively normal adults. Seventeen of 21 participants with initially elevated A beta deposition demonstrated subsequent A beta plaque growth (approximately 8.0% per year), and none reverted to a state of no A beta deposits. Ten individuals converted from negative to positive PiB status, based on a threshold of the mean cortical binding potential, representing a conversion rate of 3.1% per year. Individuals with an e4 allele of apolipoprotein E demonstrated increased incidence of conversion (7.0% per year). Our findings suggest that the major growth in A beta burden occurs during a preclinical stage of Alzheimer disease (AD), prior to the onset of AD-related symptoms. Ann Neurol 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据